Nosamplio
Consultancy providing business development, licensing and commercialization services for pharmaceutical, medical device, aesthetics and consumer health brands. Services include out‑licensing and distribution agreement support, market access and patient access strategy, strategic marketing and launch/commercialization planning, and international market entry assistance for companies targeting Europe, MENA and the Americas.
Industries
Nr. of Employees
small (1-50)
Nosamplio
Services
Advisory and execution services for licensing, out‑licensing and partner agreements for pharmaceutical and medical device assets.
Support to establish distribution agreements and European market access for diagnostics and medical devices.
Design and implementation of market access and patient access strategies to support reimbursement and uptake.
Strategic marketing planning, forecasting and execution across digital, social and traditional channels.
In‑house legal support for pharmaceutical intellectual property and licensing contracts.
Advisory and execution services for licensing, out‑licensing and partner agreements for pharmaceutical and medical device assets.
Support to establish distribution agreements and European market access for diagnostics and medical devices.
Design and implementation of market access and patient access strategies to support reimbursement and uptake.
Strategic marketing planning, forecasting and execution across digital, social and traditional channels.
In‑house legal support for pharmaceutical intellectual property and licensing contracts.
Expertise Areas
- Business development & licensing
- Pharmaceutical out-licensing
- Market access and patient access
- Commercialization and launch strategy
Key Technologies
- Digital and social media marketing
- Business intelligence and market analysis
- Licensing negotiation and contracting processes
- Market access strategy frameworks
News & Updates
Provided support for an exclusive European distribution agreement for a continuous glucose monitoring system.
Provided specialist pharmaceutical out‑licensing consultancy to secure an exclusive European licensing agreement for a novel botulinum toxin type A.
Provided support for an exclusive European distribution agreement for a continuous glucose monitoring system.
Provided specialist pharmaceutical out‑licensing consultancy to secure an exclusive European licensing agreement for a novel botulinum toxin type A.